Statin Therapy for Ischemic and Nonischemic Cardiomyopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Cardiovascular DiseaseCardiomyopathyHeart DiseaseMyocardial DiseaseMyocardial Ischemia
Interventions
DRUG

Atorvastatin Calcium

Atorvastatin Calcium starting at a 10 mg dose and may be increased up to 40 mg dose until cholesterol is lowered to an acceptable range. Blood will drawn every 2 weeks for the first 12 weeks to check the cholesterol level and adjust medication dosage. Cardiac MRI will be performed at the beginning and at the end of the 6 month study to measure the physical changes of the heart.

Trial Locations (1)

43210

The Ohio State University, Columbus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Philip Binkley

OTHER